Pfizer Inc. reported earnings results for the first quarter ended March 30, 2025. For the first quarter, the company reported revenue was USD 13,715 million compared to USD 14,879 million a year ago. Net income was USD 2,967 million compared to USD 3,115 million a year ago. Basic earnings per share from continuing operations was USD 0.52 compared to USD 0.55 a year ago. Diluted earnings per share from continuing operations was USD 0.52 compared to USD 0.55 a year ago. Basic earnings per share was USD 0.52 compared to USD 0.55 a year ago. Diluted earnings per share was USD 0.52 compared to USD 0.55 a year ago. Pfizer Inc. reported earnings results for the first quarter ended March 30, 2025. For the first quarter, the company reported revenue was USD 13,715 million compared to USD 14,879 million a year ago. Net income was USD 2,967 million compared to USD 3,115 million a year ago. Basic earnings per share from continuing operations was USD 0.52 compared to USD 0.55 a year ago. Diluted earnings per share from continuing operations was USD 0.52 compared to USD 0.55 a year ago. Basic earnings per share was USD 0.52 compared to USD 0.55 a year ago. Diluted earnings per share was USD 0.52 compared to USD 0.55 a year ago.